The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
Biochem Pharmacol
; 79(12): 1827-36, 2010 Jun 15.
Article
in En
| MEDLINE
| ID: mdl-20138024
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bromocriptine
/
Receptors, Adrenergic, alpha
/
Receptors, Dopamine D2
/
Dopamine Agonists
/
Insulin-Secreting Cells
/
Insulin
Limits:
Animals
Language:
En
Journal:
Biochem Pharmacol
Year:
2010
Document type:
Article
Affiliation country:
Netherlands